Levodopa-responsive depression associated with corticobasal degeneration: a case report

Natsumi Tarakita,1 Haruo Nishijima,2 Norio Yasui-Furukori1 1Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, 2Department of Neurology, Aomori Prefectural Central Hospital, Aomori, Japan Abstract: A 60-year-old female was treated for depression with the ant...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tarakita N, Nishijima H, Yasui-Furukori N
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/6e2f411e7847477194d0c5c47b9989c7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6e2f411e7847477194d0c5c47b9989c7
record_format dspace
spelling oai:doaj.org-article:6e2f411e7847477194d0c5c47b9989c72021-12-02T00:26:18ZLevodopa-responsive depression associated with corticobasal degeneration: a case report1178-2021https://doaj.org/article/6e2f411e7847477194d0c5c47b9989c72017-04-01T00:00:00Zhttps://www.dovepress.com/levodopa-responsive-depression-associated-with-corticobasal-degenerati-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Natsumi Tarakita,1 Haruo Nishijima,2 Norio Yasui-Furukori1 1Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, 2Department of Neurology, Aomori Prefectural Central Hospital, Aomori, Japan Abstract: A 60-year-old female was treated for depression with the antidepressant paroxetine for 13 years. The patient had experienced clumsiness and mild rigidity in the left hand, and had agraphia and mild subjective memory complaints for 3 years prior to admission in our hospital. She experienced exacerbated depression that included worsened depressive mood, lowered motivation, and suicidal ideation without precipitating stressful life events for 2 years prior to admission, and although she had continued taking the antidepressant, these symptoms were not ameliorated by increasing the dose of paroxetine. Following the development of myoclonus and pain in her left arm, we performed magnetic resonance imaging of her head, that revealed diffuse atrophy and right parietal lobe atrophy. The patient was ultimately diagnosed with corticobasal degeneration (CBD). Her left arm myoclonus and depression improved following levodopa administration. Therefore, we concluded that the recurrent depression may have been induced by CBD. Keywords: corticobasal degeneration, depression, cognitive declineTarakita NNishijima HYasui-Furukori NDove Medical Pressarticlecorticobasal degenerationdepressioncognitive declineNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 1107-1110 (2017)
institution DOAJ
collection DOAJ
language EN
topic corticobasal degeneration
depression
cognitive decline
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle corticobasal degeneration
depression
cognitive decline
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Tarakita N
Nishijima H
Yasui-Furukori N
Levodopa-responsive depression associated with corticobasal degeneration: a case report
description Natsumi Tarakita,1 Haruo Nishijima,2 Norio Yasui-Furukori1 1Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, 2Department of Neurology, Aomori Prefectural Central Hospital, Aomori, Japan Abstract: A 60-year-old female was treated for depression with the antidepressant paroxetine for 13 years. The patient had experienced clumsiness and mild rigidity in the left hand, and had agraphia and mild subjective memory complaints for 3 years prior to admission in our hospital. She experienced exacerbated depression that included worsened depressive mood, lowered motivation, and suicidal ideation without precipitating stressful life events for 2 years prior to admission, and although she had continued taking the antidepressant, these symptoms were not ameliorated by increasing the dose of paroxetine. Following the development of myoclonus and pain in her left arm, we performed magnetic resonance imaging of her head, that revealed diffuse atrophy and right parietal lobe atrophy. The patient was ultimately diagnosed with corticobasal degeneration (CBD). Her left arm myoclonus and depression improved following levodopa administration. Therefore, we concluded that the recurrent depression may have been induced by CBD. Keywords: corticobasal degeneration, depression, cognitive decline
format article
author Tarakita N
Nishijima H
Yasui-Furukori N
author_facet Tarakita N
Nishijima H
Yasui-Furukori N
author_sort Tarakita N
title Levodopa-responsive depression associated with corticobasal degeneration: a case report
title_short Levodopa-responsive depression associated with corticobasal degeneration: a case report
title_full Levodopa-responsive depression associated with corticobasal degeneration: a case report
title_fullStr Levodopa-responsive depression associated with corticobasal degeneration: a case report
title_full_unstemmed Levodopa-responsive depression associated with corticobasal degeneration: a case report
title_sort levodopa-responsive depression associated with corticobasal degeneration: a case report
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/6e2f411e7847477194d0c5c47b9989c7
work_keys_str_mv AT tarakitan levodoparesponsivedepressionassociatedwithcorticobasaldegenerationacasereport
AT nishijimah levodoparesponsivedepressionassociatedwithcorticobasaldegenerationacasereport
AT yasuifurukorin levodoparesponsivedepressionassociatedwithcorticobasaldegenerationacasereport
_version_ 1718403743890800640